Versant Capital Management’s Disc Medicine IRON Stock Holding History

Versant Capital Management’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.27K	Buy	50 +20	+67%	+$1.51K	﹤0.01%	2534
2026 Q2	$2.19K	Buy	30 +11	+58%	+$756	﹤0.01%	2553
2026 Q1	$1.22K	Hold	19	–	–	﹤0.01%	2633
2025 Q4	$1.51K	Hold	19	–	–	﹤0.01%	2481
2025 Q3	$1.26K	Hold	19	–	–	﹤0.01%	2477
2025 Q2	$1.01K	Buy	+19	New	+$892	﹤0.01%	2487

Versant Capital Management's IRON Position: Q3 2026 in Review

Versant Capital Management increased its Disc Medicine (IRON) stake by 67% in Q3 2026, buying an estimated $1.51K and bringing the position to 50 shares worth $3.27K. The position accounts for ﹤0.01% of the portfolio, ranked #2534.

Versant Capital Management first reported a position in IRON in Q2 2025 and has held it in 6 quarters since. 1 fund tracked by Wall St. Rank holds IRON as of Q3 2026.

Versant Capital Management held 50 shares of Disc Medicine worth $3.27K as of Q3 2026.
Versant Capital Management bought 20 Disc Medicine shares in Q3 2026, an estimated $1.51K.
Disc Medicine made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2534 holding.
Versant Capital Management first reported a position in Disc Medicine in Q2 2025 and has held it in 6 quarters since.
1 fund tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.